These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23160263)

  • 1. Rebuttal: the case for routine parathyroid hormone monitoring.
    Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):319-20. PubMed ID: 23160263
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Sprague SM; Moe SM
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):321. PubMed ID: 23160258
    [No Abstract]   [Full Text] [Related]  

  • 3. The case for routine parathyroid hormone monitoring.
    Sprague SM; Moe SM
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):313-8. PubMed ID: 23037984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
    Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Parathyroid Hormone and Cardiovascular Disease.
    Fujii H
    Ther Apher Dial; 2018 Jun; 22(3):236-241. PubMed ID: 29707916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Garrett G; Sardiwal S; Lamb EJ; Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):299-312. PubMed ID: 22403273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.
    Sunkara B; Cohen MS; Miller BS; Gauger PG; Hughes DT
    Surgery; 2018 Jan; 163(1):42-47. PubMed ID: 29128188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?
    Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R
    Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344
    [No Abstract]   [Full Text] [Related]  

  • 9. Features of chronic renal disease in children.
    Ivanova ON; Savvina NA; Egorova VE
    Wiad Lek; 2016; 69(3 pt 2):530-531. PubMed ID: 27717939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.
    Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R
    J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone measurement in CKD.
    Souberbielle JC; Roth H; Fouque DP
    Kidney Int; 2010 Jan; 77(2):93-100. PubMed ID: 19812537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for better PTH assays for clinical research and patient treatment.
    Hocher B; Zeng S
    Clin Chem Lab Med; 2018 Jan; 56(2):183-185. PubMed ID: 28809750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease].
    Samokhvalov NA; Maĭstrenko NA; Romashchenko PN
    Vestn Khir Im I I Grek; 2013; 172(2):43-6. PubMed ID: 24000678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
    Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
    J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone measurements, guidelines statements and clinical treatments: a real-world cautionary tale.
    Garrett G; Goldsmith DJ
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):4-6. PubMed ID: 22218488
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary Hyperparathyroidism in Heart Failure.
    Morsy MS; Dishmon DA; Garg N; Weber KT
    Am J Med Sci; 2017 Oct; 354(4):335-338. PubMed ID: 29078836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus on vitamin D therapy in chronic kidney disease.
    Tentori F
    J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
    Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients.
    Eddington H; Hudson JE; Oliver RL; Fraser WD; Hutchison AJ; Kalra PA
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):228-36. PubMed ID: 24000371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.